July 29, 2014
1 min read
Save

New Zealand subpopulation with HBV faced increased risk for HCC, mortality

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

People of Māori descent in New Zealand who acquired horizontally transmitted hepatitis B virus had an increased risk for hepatocellular carcinoma and liver-related mortality, according to recent study results.

Researchers conducted a comprehensive population seroprevalence study in the Kawerau township of New Zealand between February and April 1984. All residents were tested for current or past hepatitis B virus (HBV). Of 8,568 residents reviewed, 572 were positive for hepatitis B surface-antigen (HBsAg) and entered into the long-term study with monthly follow-ups.

Researchers also added a cohort of 1,140 healthy controls, two for every HBsAg patient. Forty-one percent of the population was positive for the hepatitis B e-antigen (HBeAg). In 2012, 565 of the patients with HBsAg had data available for final analysis; median number of follow-ups per patient was 15.

By 2012, 54 patients positive for HBsAg had died compared with 107 deaths in the HBsAg-negative group. Among HBsAg patients, the cumulative probability of survival was 97.5% and 90.2% at 10 years and 28 years, respectively; while rates for controls were 97.8% and 90.6% at the same follow-ups.

Fifteen patients positive for HBsAg developed hepatocellular carcinoma (HCC) over 28 years vs. no controls (P<.001), and HCC incidence was greater in patients with HBsAg. Twelve patients positive for HBsAg died from a liver-related complication due to advanced HCC, while none died among controls (P<.0001). HBsAg and HBeAg seroconversion rates were 33% and 92%, respectively, and median ages at loss were 40 years and 23 years, respectively. Ten percent (n=33) of surviving patients positive for HBsAg developed cirrhosis after 28 years, with an incidence rate of 366 per 100,000 person-years.

“Horizontally transmitted HBV in Māori is similarly associated with increased risk of liver-related mortality and HCC compared with Chinese, although absolute incidence rates are lower,” the researchers concluded.

Disclosure: The researchers report no relevant financial disclosures.